|Bid||4.4200 x 1100|
|Ask||4.4300 x 900|
|Day's Range||4.3000 - 4.4800|
|52 Week Range||3.4600 - 13.0000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 10, 2021 - Aug 16, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||12.00|
Biocept reports profitability for the second consecutive quarter on revenues of $17.8 million for the first quarter of 2021.
NEW YORK, NY / ACCESSWIRE / May 12, 2021 / Biocept, Inc. (NASDAQ:BIOC) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 12, 2021 at 4:30 PM Eastern Time.
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that it will release financial results for the three months ended March 31, 2021 after the market closes on Wednesday, May 12, 2021. The Company will host a conference call for the investment community to discuss the results and answer questions at 4:30 p.m. Eastern time (1:30 p.m. Pacific time).